Ribomic Inc. (TYO:4591)

Japan flag Japan · Delayed Price · Currency is JPY
110.00
-6.00 (-5.17%)
Jul 15, 2025, 3:30 PM JST
22.22%
Market Cap 5.17B
Revenue (ttm) 2.00M
Net Income (ttm) -1.02B
Shares Out 44.59M
EPS (ttm) -25.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,064,300
Average Volume 3,974,020
Open 115.00
Previous Close 116.00
Day's Range 110.00 - 116.00
52-Week Range 60.00 - 141.00
Beta 0.47
RSI 62.22
Earnings Date Aug 12, 2025

About Ribomic

Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan. The company develops drugs for wet age-related macular degeneration, achondroplasia, pulmonary arterial hypertension, proliferative vitreoretinopathy, heart failure, osteoarthritis, and asthma, as well as separating agents for affinity purification of human IgG and Fc-fusion proteins. Ribomic Inc. was incorporated in 2003 and is headquartered in Tokyo, Japan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2003
Employees 25
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4591
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.